CANADA’S NATIONAL LABORATORY FOR PARTICLE AND NUCLEAR PHYSICSOwned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada

LABORATOIRE NATIONAL CANADIEN POUR LA RECHERCHE EN PHYSIQUE NUCLÉAIRE ET EN PHYSIQUE DES PARTICULES  

Propriété d’un consortium d’universités canadiennes, géré en co-entreprise à partir d’une contribution administrée par le Conseil national de recherches Canada

A Vision for the Next DecadeAchieving Canada’s Research Goals &

Leading the Knowledge-Based EconomyNigel S. Lockyer, Director/Directeur

Une Vision pour la prochaine décennie atteindre les objectifs de recherche du Canada et paver le chemin

de l’économie du savoir

PET Radiotracer Superconducting Cavity1st Made in Canada

2009 March 5 22

Owned and Operated by a Consortium of 14 Universities

7 full members & 7 associate members

MembersCarleton UniversitySimon Fraser UniversityUniversity of AlbertaUniversity of BCUniversité de MontréalUniversity of TorontoUniversity of Victoria

Associate MembersMcMaster UniversityQueen’s University*Saint Mary’s UniversityUniversity of Guelph*University of Manitoba*University of ReginaYork University*

99 Year lease

2009 March 5 3

2009 March 5 44

Awards and RecognitionTRIUMF team widely recognized for excellence• Ryu Hayano, Japan’s Nishina Memorial Prize 2008 • Jess Brewer, CAP Brockhouse Prize • Carl Svensson, NSERC Steacie Fellowship & CAP Herzberg• Dugan O’Neil, BC Innovation Council Young Innovator Prize• Mike Barnes, on location 3 years to commission LHC• Pierre Savard, Exotics Physics Group Leader, ATLAS• Two NSERC Synergy Awards (MDS Nordion, D-PACE)• Mark Martinez, BC Lieutenant Gov. Techn. Innovation Award• Igor Sekachev, US Nat’l Academies, helium shortage cttee• Tom Ruth, US Nat’l Academies, medical isotopes cttee(HEU)• Vesna Sossi, Michael Smith Foundation Fellowship• David Sinclair, Carleton U. Medal for Distinguished Research

2009 March 5 55

TRIUMF Attracts Top Talent to Canada

• Lia Merminga, Head of Accelerator Division (USA)– Elected Chair ‘10 American Physical Society Beams Division

• Vaishali Naik, VECC visiting accelerator scientist (India)• Cornelia Hoehr, nuclear medicine (Germany)• Oliver Stetzler, particle physics LHC (Germany)• Anadi Canepa, particle physics LHC (Italy)

• ATLAS Canada graduate students– Currently 65 students, plan for ~100– 1/3 on NSERC Fellowships– 1/3 international

• 40% of students at TRIUMF are international

2009 March 5 66

Present Successes

2009 March 5 77

Excellence in Nuclear Science A New Era in Mass Measurements

• Highest power Rare Isotope Beam (RIB) facility in world• Most intense beams of certain species in world• A dozen world-class experiments on floor

– Supported by NSERC through peer-review process

11Li

CERN TRIUMF

2008

CERN

Astrophysics Highlights 2008/2009

• June 2008: 18F(p,p)18F and 18F(p,)15O at TUDA – Highest 18F intensity for this reaction so far

• November 2008: First direct measurement of 23Mg(p,)24Al at DRAGON

• December 2008: Implantation of 22Na targets at ISAC• December 2008: ISAC-II measurement of lifetime of 6.79 MeV state

in 15O for 14N(p,)15O reaction rate determination• February 2009: 22Na(p,)23Mg using ISAC targets at University of

Washington, Seattle

• Details in presentations• 5-year plan has astrophysics prominent2009 March 5 8

2009 March 5 92008 Dec 8 9

Leading Rare Isotope Facilities Leading Rare Isotope Facilities

Global investment in RIBs over next decade ~$4B (OECD)

2009 March 5 1010

ATLAS Canada

TRIUMF design built at Alstom Tracy Quebec

Total Investment by Canada ~$100M

Delivered on time, on budget, working well

Hadronic Endcap & Forward Calorimeter

2009 March 5 1111

Knowledge Transfer & Commercialization

• TRIUMF bridges commercial and academic sectors– Research Innovation Commercialization

• Partnership with MDS Nordion is model program for the world – Produces 2.5 million patient doses of medical isotopes per year– ~3000 patient doses of FDG to BCCA per year– More than 125 patients ocular melanoma with protons (BCCA)– NSERC Synergy Award 2003– R&D partnership in value-added isotopes launched October 2008

• D-PACE (NSERC Synergy Award 2007)• TRIUMF-designed cyclotrons in use worldwide• Advanced Applied Physics Solutions (AAPS) Inc.

– First-round Centre of Excellence Commercialization & Research (CECR) • $2.25M partnership with physics institute in India (signed Aug 2008)• Si-32 MOU with US for phytoplankton research (only source in NA)

2009 March 5 1212

The 5-Year Plan

2009 March 5 1313

5-Year PlanBuilding on Opportunities

• TRIUMF is poised for a transformation– Opportunities, skills, and past investments are coming together

• Future plan seizes 3 new strategic opportunities– Platform technology: superconducting RF (SRF)

• Accelerators, medical-isotope production, flue-gas scrubbing– Platform technology: nuclear medicine

• Lead emerging revolution – Playing a major role in world’s largest scientific project: LHC

• Canadian Physics Analysis Centre & Tier-1 Data Centre

• Requested investments – $328M for 2010-2015 operations– $60M for capital infrastructure (buildings)

2009 March 5 1414

Success: EF5-18F (a first in Canada)

Tests for Hypoxia – radiation-resistant tumours

2009 March 5 1515

Excellence in Nuclear Medicine• Program started in neurology, expanding to oncology

– World leading Pacific Parkinson’s Research Centre (PPRC) (1500 patient visits a year)

• Entire program depends on TRIUMF• Major discoveries: Placebo effect; Trauma origins

– Core competencies• PET Imaging (synergy with $43M animal care facility—rabbit line)• Radiochemistry and biomarkers (18F, 11C….)• Target development techniques

• “This entire field of application is predicated on radiotracer creation, radiopharmaceutical preparation, radiochemistry and interpretative radiobiology—all aspects established within the practical and intellectual domain of TRIUMF.” —Simon B. Sutcliffe, CEO BCCA

2009 March 5 1616

Nuclear Medicine RevolutionDrives Personalized Medicine

• “The level of knowledge and expertise within TRIUMF and MDS Nordion gives us a unique global competitive advantage…”

– Steve West, President, MDS Nordion

• Disease metabolism subject to detailed investigation with targeted labeled molecules --- amino acid transporters, peptides… etc

• Establish cancer staging (metastasis) & efficacy of treatment with quick turn around (FDG PET)

– Dr. Dan Worsley stated that the introduction of PET/CT scans at the BCCA resulted in changes to more than 50% of the treatments for scanned patients

• Move towards imaging and therapy isotopes for cancer treatment (alpha emitters), e.g., 211At

• Leads to mini SC cyclotron (espresso maker) in every hospital AAPS

2009 March 5 1717

Institutions Partnering w/TRIUMF

• UBC/TRIUMF (Lead)• McMaster University• Cross Cancer Institute• MNI• Ottawa Heart Institute• Université de Sherbrooke

• BC Cancer Agency• St Joseph's Health Care • Sunnybrook• Thunder Bay• University Health Network

(PMH)• University of Calgary• Dalhousie University• University of Manitoba• Université de Montréal

Active Cyclotron Based Programs Establishing Cyclotron Programs

Terry Fox Research Institute

2009 March 5 1818

CECRs Partnering w/TRIUMF• Advanced Applied Physics Solutions, Inc. (AAPS),

Vancouver, BC

• Centre for Drug Research and Development (CDRD), Vancouver, BC

• The Prostate Centre’s Translational Research Initiative for Accelerated Discovery and Development (PC-TRIADD), Vancouver, BC

• Centre for Probe Development and Commercialization (CPDC), Hamilton, ON

2009 March 5 1919

TRIUMF is becoming a leading SRF science and technology center.

SRF at TRIUMF: past, present, future ISAC II Phase I106 MHzβ =0.057, 0.071Ep=30 MV/m

ISAC II Phase II141 MHzβ =0.11Ep= 30 MV/m

E-linac/VECC1.3 GHzβ = 1Ep= 20 MV/m

SPL 704 MHz β = 0.65, 1 Ep= 50 MV/m

ILC1.3 GHzβ = 1Ep= 63 MV/m

2009 March 5 2020

World Leadership in RIBs• Goal of 5-yr plan – exploit SRF technologies for RIBS

• Unique moment to seize scientific discovery opportunity– Study neutron-rich nuclei important for element abundances,

supernova explosions, neutron-star crusts, shell structure, theory advances, universal nuclear density functional, 3-nucleon interactions,...

– Great opportunity in fundamental symmetries (one of holy grails in nuclear physics) --- Prize winning science

– TRIUMF has strong fleet of experiments & eager young researchers– Large international user base wanting and waiting for varied beams – Accelerator team strong & unique in Canada

• Canada: Opportunity to lead on world nuclear physics stage

2009 March 5 2121

Outlook

Economic Impacts of TRIUMF & Proposed Expansion

Estimated Impacts 2009 – 2014

BC: $60.7m one time

NRC: $328m NSERC: $35m CFI: $18m Others: $48m

& others

Fast job creation:TRIUMF expansion to create a total of 179 person-years of

construction work (inc. 71 FTE by 2010)

Five-year economic impacts:• $912 million total provincial output• $511 million total provincial GDP• 1,284 permanent FTE jobs• $50 million provincial tax revenues

• World-leading particle & nuclear physics research facility & program

• Heart of a growing BC advanced tech cluster (MDS, BCCA, PAVAC, etc.)

• Canada’s leader in global “big science” (CERN-LHC, T2K, CSUNS, etc.)

• Research applications in technologies relevant to British Columbia: nuclear medicine, environment, natural resources, aerospace, electronics

2009 March 5 22

Richmond, BC±20 employees

Vancouver, BC±90 employees

Vancouver, BC±5 employees

Richmond, BC±20 employees

Vancouver, BC±15 imaging staff

National & International

Communities

Particle Accelerator

& Nuclear Medicine

Nelson, BC±10 employees

Vancouver, BC±475 employees

2009 March 5 23

2009 March 5 2424

The 5-year plan is an opportunity for TRIUMF and the university community to

position Canada as a lead nation in science & technology

2009 March 5 25

4004 Wesbrook Mall Vancouver, B.C. Canada V6T 2A3

Tel: 604 222-1047 Fax: 604 222-1074www.triumf.ca

Thank you

Merci